Literature DB >> 25378212

Vaccine-preventable travel health risks: what is the evidence--what are the gaps?

Robert Steffen1, Ron H Behrens, David R Hill, Christina Greenaway, Karin Leder.   

Abstract

BACKGROUND: Existing travel health guidelines are based on a variety of data with underpinning evidence ranging from high-quality randomized controlled trials to best estimates from expert opinion. For strategic guidance and to set overall priorities, data about average risk are useful. The World Health Organization (WHO) plans to base future editions of "International Travel and Health" on its new "Handbook for Guideline Development."
METHODS: Based on a systematic search in PubMed, the existing evidence and quality of data on vaccine-preventable disease (VPD) risks in travelers was examined and essentials of vaccine efficacy were briefly reviewed. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework was used to evaluate the quality of the data.
RESULTS: Moderate-quality data to determine the risk of VPD exist on those that are frequently imported, whereas in most others the level of confidence with existing data is low or very low.
CONCLUSIONS: In order for the WHO to produce graded risk statements in the updated version of "International Travel and Health," major investment of time plus additional high-quality, generalizable risk data are needed.
© 2014 International Society of Travel Medicine.

Mesh:

Substances:

Year:  2014        PMID: 25378212     DOI: 10.1111/jtm.12171

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  16 in total

Review 1.  Truth and direct-to-consumer advertising in Canada of DUKORAL for traveler's diarrhea prevention.

Authors:  Rudy Zimmer
Journal:  Can Fam Physician       Date:  2019-03       Impact factor: 3.275

2. 

Authors:  Rudy Zimmer
Journal:  Can Fam Physician       Date:  2019-03       Impact factor: 3.275

Review 3.  Travel vaccines: Update for Canadian pharmacists.

Authors:  Christina Bascom
Journal:  Can Pharm J (Ott)       Date:  2019-10-11

Review 4.  Vaccines and Senior Travellers.

Authors:  Fiona Ecarnot; Stefania Maggi; Jean-Pierre Michel; Nicola Veronese; Andrea Rossanese
Journal:  Front Aging       Date:  2021-07-09

5.  Self-reported illness among Boston-area international travelers: A prospective study.

Authors:  Lin H Chen; Pauline V Han; Mary E Wilson; Rhett J Stoney; Emily S Jentes; Christine Benoit; Winnie W Ooi; Elizabeth D Barnett; Davidson H Hamer
Journal:  Travel Med Infect Dis       Date:  2016-10-02       Impact factor: 6.211

6.  Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO®).

Authors:  D Amicizia; F Zangrillo; P L Lai; M Iovine; D Panatto
Journal:  J Prev Med Hyg       Date:  2018-03-30

7.  Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products.

Authors:  Soyoung Lee; Han Wool Kim; Kyung Hyo Kim
Journal:  J Korean Med Sci       Date:  2016-12       Impact factor: 2.153

Review 8.  Travellers and influenza: risks and prevention.

Authors:  M Goeijenbier; P van Genderen; B J Ward; A Wilder-Smith; R Steffen; A D M E Osterhaus
Journal:  J Travel Med       Date:  2017-01-11       Impact factor: 8.490

9.  Self-reported infections during international travel and notifiable infections among returning international travellers, Sweden, 2009-2013.

Authors:  Viktor Dahl; Anders Wallensten
Journal:  PLoS One       Date:  2017-07-28       Impact factor: 3.240

10.  Imported Infections in Rural Mid-West United States - A Report from a Tertiary Care Center.

Authors:  Amy Meyer; Hariharan Regunath; Christian Rojas-Moreno; William Salzer; Gordon Christensen
Journal:  Mo Med       Date:  2020 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.